Related Experiment Video
Updated: Jun 15, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus
1Section of Cardiology, Department of Medicine, Boston Medical Center, Boston University School of Medicine, 88 East Newton Street, Boston, MA 02118, USA.
Insights
Coronary artery disease (CAD) is a major risk for patients with diabetes mellitus (DM). Identifying which diabetic patients need aggressive CAD treatment remains challenging despite risk factor reduction strategies.
Area of Science:
- Cardiology
- Endocrinology
- Medical Diagnostics
Background:
- Coronary artery disease (CAD) is the leading cause of death and illness in individuals with diabetes mellitus (DM).
- Current treatment paradigms emphasize aggressive risk factor reduction for all DM patients, irrespective of diagnosed CAD or symptoms.
- A significant clinical challenge lies in identifying diabetic patients who would benefit most from intensive, invasive therapeutic approaches.
Purpose of the Study:
- To review the diagnostic and prognostic utility of conventional non-invasive methods for assessing CAD in diabetic patients.
- To explore novel and emerging techniques for CAD risk stratification in the context of diabetes.
Main Methods:
- Literature review of diagnostic and prognostic modalities for CAD in DM.
- Analysis of conventional non-invasive assessment tools.
- Evaluation of emerging risk stratification methods.
Main Results:
- Conventional non-invasive methods have limitations in definitively identifying high-risk diabetic patients for aggressive intervention.
- Emerging techniques show promise for improved CAD risk stratification in diabetic populations.
- Accurate risk stratification is crucial for tailoring treatment strategies in diabetic patients with CAD.
Conclusions:
- Improved diagnostic and prognostic tools are needed to guide aggressive CAD treatment in diabetic patients.
- Novel risk stratification methods may enhance clinical decision-making for CAD management in DM.
- Personalized approaches to CAD management in diabetes are essential for reducing morbidity and mortality.
Abstract:
Coronary artery disease (CAD) continues to be the most common cause of morbidity and mortality in patients with diabetes mellitus (DM). In recent years, the strategies for treatment of CAD in DM have undergone much evolution. Currently, all patients with DM, regardless of symptoms or diagnosed CAD, are treated aggressively for CAD risk factor reduction. In this clinical climate, the ability to specifically identify patients with disease that will benefit from more aggressive and invasive therapies remains a challenge. In this article we review the current literature on diagnostic and prognostic utility of conventional non-invasive modalities for assessment of CAD in patients with DM, as well as on novel and emerging methods for CAD risk stratification.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease V: Interprofessional Care
Dysrhythmias V: Evaluating Dysrhythmias
Coronary Artery Disease I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
